Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation
- PMID: 11439749
- DOI: 10.1023/a:1005626100084
Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation
Abstract
Atypical antipsychotic medications for self-injurious behavior (SIB), aggression, and destruction among people with mental retardation and development disabilities are becoming increasingly accepted. Most studies are on risperidone and fewer have been conducted on clozapine. The present single-blind study reports marked reductions in SIB and aggression of two persons with profound mental retardation who were nonresponsive to all other behavioral and psychopharmacological interventions, including risperidone. The most effective dose was 200 mg/day. Side effects were mild and the drug was tolerated well.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical